IMRX · Immuneering Corp · Investor Relations
$3.68
-0.14 (-3.54%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$246.50M
Shares
64.70M
Volume · Oct 23
516.52K
Avg daily vol (3M)
680.8K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-14 | H.C. Wainwright 28th Annual Global Investment Conference | Conference |
| 2026-09-10 | Cantor Global Healthcare Conference | Conference |
| 2026-06-01 | Atebimetinib ASCO Data Update in 1L Pancreatic Cancer | Webcast |
| 2026-04-13 | 25th Annual Needham Virtual Healthcare Conference | Conference |
| 2026-03-09 | Leerink Global Healthcare Conference | Conference |
| 2026-02-26 | Oppenheimer 36th Annual Healthcare Life Sciences Conference | Conference |
| 2026-01-07 | Atebimetinib Updated 12-mth Overall Survival Data in 1L Pancreatic Cancer | Webcast |
| 2025-12-04 | Piper Sandler 37th Annual Healthcare Conference | Conference |
| 2025-11-12 | Q3 2025 Immuneering Corporation Earnings Conference Call | Earnings call |
| 2025-09-29 | Phase 2a Data Update for IMM-1-104 in First-Line Pancreatic Cancer | Webcast |
Source: https://ir.immuneering.com/
Key facts
CIK
1790340
CUSIP
45254E107
13F (30d)
14 filings
14 filers
Visit website
Investor relations